ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Health Services Research"

  • Abstract Number: 1008 • ACR Convergence 2023

    Identifying Inflammatory Arthritis Ambulatory Care Service Model Enhancements Needed to Reduce Avoidable Emergency Department Use

    Emilie Pianarosa1, Pamela Roach1, Patrick McLane2, Meghan Elliott1, Brian Holroyd3, Shanon McQuitty4, Steven Katz3, Nazret Russon2, Katie Lin1, Claire Barber1 and Cheryl Barnabe1, 1University of Calgary, Calgary, AB, Canada, 2Alberta Health Services, Edmonton, AB, Canada, 3University of Alberta, Edmonton, AB, Canada, 4Arthritis Research Canada, Vancouver, BC, Canada

    Background/Purpose: Emergency departments (ED) become a location for non-urgent care when ambulatory care systems are not sufficient. We aim to describe contributing factors to the…
  • Abstract Number: 1845 • ACR Convergence 2023

    Development of a Scoring System for Accurate Lupus Nephritis Case Identification in Real-World Databases

    Zara Izadi1, Alfredo Aguirre1, Christine Anastasiou1, Julia Kay1, Gabriela Schmajuk2 and Jinoos Yazdany3, 1University of California San Francisco, San Francisco, CA, 2UCSF / SFVA, San Francisco, CA, 3University of California, General Department of Medicine, Division of Rheumatology, San Francisco, CA

    Background/Purpose: Accurate identification of prevalent cases of lupus nephritis (LN) is essential for timely patient monitoring and treatment, advancing research, and informing public health initiatives…
  • Abstract Number: 2257 • ACR Convergence 2023

    Outcomes and Clinical Features of Acute Coronary Syndrome in Patients with SLE: A 14-Year Real-World Study (2006-2019)

    Konstantinos Parperis1 and Bikash Bhattarai2, 1University of Cyprus Medical School, Nicosia, Cyprus, 2Valleywisehealth, Phoenix, AZ

    Background/Purpose: Systemic Lupus Erythematosus (SLE) is an autoimmune inflammatory disease associated with an increased risk of cardiovascular complications, including acute coronary syndrome (ACS). However, there…
  • Abstract Number: 088 • 2023 Pediatric Rheumatology Symposium

    Quality Improvement Cycles to Actualize Distribution of the Adolescent Assessment of Preparation for Transition (ADAPT) Survey

    David McDonald1, Kristiana Nasto1, Kyla Fergason1, Mary Robichaux1, Bernard Danna1, Monique Maher1, Alexander Alexander1, Ariel Coleman2, Anne Dykes2, JaLeen Rogers2, Miriah Gillispie-Taylor1 and Tiphanie Vogel1, 1Baylor College of Medicine, Houston, TX, 2Texas Children's Hospital, Houston, TX

    Background/Purpose: The challenges of transitioning patients with chronic rheumatic diseases from pediatric to adult care can lead to increased morbidity and mortality following transfer. Therefore,…
  • Abstract Number: 0076 • ACR Convergence 2022

    Real World Rheumatology Practice of Biologic Monotherapy for the Treatment of Patients with Rheumatoid Arthritis: A Four-year Cohort Study Using a National Claims Database

    Ko-Jen Li1, Kuo-Cherh Huang2, Chia-Cheng Lin3 and Chia-Li Chang2, 1National Taiwan University Hospital, Taipei, Taiwan, 2Taipei Medical University, Taipei, Taiwan, 3Chugai Pharma Taiwan Ltd., Taipei, Taiwan

    Background/Purpose: There is a growing concern over the rise of polypharmacy, arguably one of the most pressing prescribing challenges. The option of biologic monotherapy is…
  • Abstract Number: 0570 • ACR Convergence 2022

    Clarifying Misbeliefs About Hydroxychloroquine (HCQ): Developing an Evidence-Based HCQ Benefits vs. Risk Decision Aid (HCQ-SAFE) Per Low Health Literacy Standards

    Shivani Garg1, Sancia Ferguson2, Betty Chewning3, Shelby Gomez4, Jon Keevil5 and Christie Bartels6, 1University of Madison, School of Medicine and Public Health, Madison, WI, 2University of Wisconsin School of Medicine & Public Health, Madison, WI, 3University of Wisconsin, School of Pharmacy, Madison, WI, 4UW Health, Stoughton, WI, 5NA, Madison, WI, 6University of Wisconsin School of Medicine and Public Health, Madison, WI

    Background/Purpose: Studies report ~83% of SLE patients discontinue hydroxychloroquine (HCQ) and many report suboptimal shared decision-making with their healthcare team. Moreover, patients report knowledge gaps…
  • Abstract Number: 1799 • ACR Convergence 2022

    Evaluation of Adherence to and Agreement with the 2020 American College of Rheumatology Guideline for the Management of Gout by US Rheumatologists

    Naomi Schlesinger1, Michael Pillinger2 and Peter Lipsky3, 1Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ, 2NYU Grossman School of Medicine, New York, NY, 3AMPEL BioSolutions, Charlottesville, VA

    Background/Purpose: The American College of Rheumatology (ACR) developed an updated guideline in 2020 for the management of gout.1 This study evaluates US rheumatologists' stated adherence…
  • Abstract Number: 0080 • ACR Convergence 2022

    Utilization of Biologic and Targeted Disease Modifying Antirheumatic Therapy in Patients with Rheumatoid Arthritis and Breast Cancer

    Juan Ruiz1, Chi-Fang Wu2, Hui Zhao2, Sharon Giordano2, Suja Rajan3 and Maria Suarez-Almazor4, 1The University of Texas MD Anderson Cancer Center, Houston, TX, 2The University of Texas, MD Anderson Cancer Center, Houston, TX, 3University of Texas School of Public Health, Houston, TX, 4MD Anderson Cancer Center, Houston, TX

    Background/Purpose: Biologic and targeted synthetic disease modifying antirheumatic drugs (bDMARD and tsDMARD) are immunosuppressant, and there have been concerns that they might impact tumor immunity…
  • Abstract Number: 0678 • ACR Convergence 2022

    Inpatient Epidemiology, Expenditures and Resource Utilization of Antiphospholipid Syndrome: National Inpatient Sample 2019

    Patompong Ungprasert1, Sunisa Kongkiatkamon2, Ben Ponvilawan3, Nuttavut Sumransub4 and Paul Kroner5, 1Cleveland Clinic, Cleveland Heights, OH, 2Chulalongkorn University, Bangkok, Thailand, 3Department of Internal Medicine, University of Missouri-Kansas City School of Medicine, Kansas City, MO, 4University of Minnesota, Minneapolis, MN, 5Mayo Clinic, Jacksonville, FL

    Background/Purpose: Little is known about inpatient epidemiology, morbidity, mortality and resource utilization of patients with antiphospholipid syndrome (APS). The purpose of this study is to…
  • Abstract Number: 1810 • ACR Convergence 2022

    Frequency and Patterns of Opioid Use in the Management of Gout: A Population-Based Study

    Tuhina Neogi1, Martin Englund2, Aleksandra Turkiewicz2 and Ali Kiadaliri2, 1Boston University School of Medicine, Boston, MA, 2Lund University, Lund, Sweden

    Background/Purpose: Treatment guidelines for management of gout do not recommend opioids. We evaluated the frequency of opioid prescriptions in those with gout compared with the…
  • Abstract Number: 0081 • ACR Convergence 2022

    Impact of the COVID-19 Pandemic on Rheumatology Services in a Universal Healthcare Setting in Canada: A Population-based Study

    Timothy Kwok1, Bindee Kuriya1, Lauren King1, Lihi Eder2, Carter Thorne3, Zhiyin Li4, therese stukel4, longdi fu4, alexander Kopp4 and Jessica Widdifield5, 1University of Toronto, Toronto, ON, Canada, 2Women’s College Research Institute, Department of Medicine, University of Toronto, Toronto, ON, Canada, 3Southlake Regional Health Centre, Newmarket, ON, Canada, 4ICES, Toronto, ON, Canada, 5Sunnybrook Research Institute, Toronto, ON, Canada

    Background/Purpose: We sought to describe changes in service delivery and access to rheumatologists in terms of changes in weekly total office visit volumes, telemedicine visits,…
  • Abstract Number: 0734 • ACR Convergence 2022

    Comfort Levels and Practice Patterns for Osteoporosis-Related Care Among Persons Living with HIV in Peru: A National Physician Survey

    Rebecca Slotkin1, Camila Lucero Granda Calderón2, Diego Cabrera3, Carlos Manuel Benites Villafane4, Patricia Jannet Garcia5 and Evelyn Hsieh3, 1Yale University School of Public Health, New Haven, CT, 2Facultad de Medicina Alberto Hurtado de la Universidad Peruana Cayetano Heredia, Lima, Peru, 3Section of Rheumatology, Allergy and Immunology, Yale School of Medicine, New Haven, CT, 4Ministerio de Salud, Lima, Peru, 5Epidemiology, STD, and HIV Unit, School of Public Health, Universidad Peruana Cayetano Heredia, Lima, Peru

    Background/Purpose: As they age, persons living with HIV (PLWH) are at increased risk for osteoporosis due to chronic infection and antiretroviral therapies (ART). In Peru,…
  • Abstract Number: 1888 • ACR Convergence 2022

    Novel Small Molecule Modulator of the gp130 Receptor Shows Dose-dependent Therapeutic Efficacy in a Canine Model of Osteoarthritis

    Ben Van Handel1, Candace Flynn2, Emma Lamoure2, Nancy Liu3, Jinxiu Lu3, Nancy Lane4, Mark Hurtig2 and Denis Evseenko3, 1CarthroniX, Inc., Los Angeles, CA, 2University of Guelph, Guelph, ON, Canada, 3University of Southern California, Los Angeles, CA, 4University of California Davis, Hillsborough, CA

    Background/Purpose: The pathogenesis of OA often begins from an injury to articular cartilage, which establishes chronic, low-grade inflammation principally mediated by IL-6 family cytokines that…
  • Abstract Number: 0082 • ACR Convergence 2022

    Impact of the COVID-19 Pandemic on Healthcare Utilization Among Rheumatoid Arthritis, Psoriatic Arthritis and Systemic Lupus Erythematosus Patients

    Jean Park, W. Cliff Rutter, Will Cavers, Elisea Avalos-Reyes and Kjel Johnson, CVS Health, Lincoln, RI

    Background/Purpose: Patients with rheumatoid arthritis (RA), psoriatic arthritis (PsA) and systemic lupus erythematosus (SLE) are considered at risk for serious COVID infections due to their…
  • Abstract Number: 0735 • ACR Convergence 2022

    Facilitators and Barriers to Weekly Monitoring of Disease Activity with Electronic Patient Reported Outcomes: A Focus Group Study of Patients with Inflammatory Arthritis

    Jim Wiegel1, Bart Seppen2, Michael Nurmohamed3, Marieke ter Wee4 and Wouter Bos1, 1Reade Rheumatology Center, Amsterdam, Netherlands, 2Vrije Universiteit | Reade, Amsterdam, Netherlands, 3Amsterdam University Medical Center, Kortenhoef, Netherlands, 4Amsterdam University Medical Centers, Vrije Universiteit, Amsterdam, Netherlands

    Background/Purpose: Telemonitoring disease activity with electronic patient reported outcomes (ePRO's) may reduce the workload of rheumatic care by decreasing outpatient clinic visits. However, low adherence…
  • « Previous Page
  • 1
  • …
  • 8
  • 9
  • 10
  • 11
  • 12
  • …
  • 18
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology